Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : | NSE Symbol : | ISIN : | Industry : |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-May-2024	30-May-2024	Accounts	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Board Meeting Intimation for to Consider the Standalone & Consolidated Audited Financial Results For The Year Ended 31.03.2024 Intimation of cancellation of Board meeting which was scheduled on 30.05.2024 (As Per BSE Announcement Dated on 30.05.2024)
22-Apr-2024	22-Apr-2024	Change in Auditors	Board of Directors in their just concluded Board meeting held today have: 1. Recommended the reappointment of M Surendra & Associates, Chartered Accountants, Hyderabad (FRN No: 017280S) for a second term of 5 years, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting; 2. Decided to convene the Twenty Fifth Annual General Meeting on 23.05.2024; 3. Decided to close the Register of Members and Share Transfer Books from 21st May, 2024 to 23rd May, 2024 (both days inclusive) for the purpose of Annual General Meeting for the financial year 2022-23 scheduled to be held on 23rd May, 2024; 4. Approved the appointment of Mr.Dattatreya Rao (DIN: 09719501) as Executive Director & Chief Executive Officer (CEO) of the Company for a term of five years effective from 22nd April 2024 to 21st April 2029, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting; 5. Noted the resignation of Mr.Amarachinta Padmanabha Rao (DIN 08229256), Non- Executive Independent Director of the Company 6. Noted the demise of Dr. Devarakonda Chidvilasa Sastri (DIN 02682897), Non-Executive Independent Director of the company (As Per BSE Bulletin Dated on 22.04.2024) Outcome of the Board Meeting held on 22.04.2024 - Reappointment of statutory auditors, appointment of executive director & Chief Executive Officer, Resignation of Independent director & demise of independent director Resignation of Mr.Amarachinta Padmanabha Rao, Non-executive Independent director of the company Demise of Dr Devarakonda Chidvilasa Sastri, Non-executive Independent director of the company Appointment of Mr.Dattatreya Rao as Executive Director and Chief Executive Officer of the Company (As Per BSE Announcement dated on 22.04.2024)
23-Mar-2024	29-Mar-2024	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 this is to intimate you that a meeting of the Board of Directors and Audit Committee of the Company is schedule to be held on 29.03.2024: 1) to consider and take on record the standalone audited financial results & consolidated audited financial results of the Company for the quarter / year ended 31.03.2023; 2) to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / 3 months ended 30.06.2023; 3) to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / half year ended 30.09.2023; 4)to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / nine months ended 31.12.2023 Considered and adopted the standalone and consolidated results for Q4 of 2022-23, Q1, Q2 and Q3 of FY 2023-24 Results for Q2 of FY 2023-24 (As per BSE Announcement Dated on 29/03/2024)
29-Feb-2024	06-Mar-2024	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2024 inter alia to consider and approve 1) the audited financial results of the Company for the quarter / year ended 31.03.2023 2) the Un-audited financial results of the Company for the quarter / 3 months ended 30.06.2023 3) the Un-audited financial results of the Company for the quarter / half year ended 30.09.2023 4) the Un-audited financial results of the Company for the quarter / nine months ended 31.12.2023 This is to inform you that the Board meeting of the company which was scheduled on 06.03.2024 stand cancelled due to non-availability of Independent directors (As per BSE Announcement Dated on 11/03/2024)
08-Feb-2023	14-Feb-2023	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Prior Intimation of the Board Meeting to be held on 14.02.2023 to consider and take on record the Un-audited financial results of the Company for the quarter / nine months ended 31.12.2022 Outcome of the Board Meeting to consider and adopt the Un-audited financial results of the Company for the quarter / nine months ended 31.12.2022 The Un-audited financial results of the Company for the quarter / nine months 31.12.2022 (As per BSE Announcement Dated on 14/02/2023)
08-Nov-2022	14-Nov-2022	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Prior Intimation of the Board Meeting and Audit Committee Meeting to be held on 14.11.2022 - Un-audited Financial Results for the quarter ended 30.06.2022 & for the half year ended 30.09.2022 Outcome of the Board Meeting to consider and adopt the Un-audited financial results of the Company for the quarter ended 30.06.2022 & 30.09.2022 the Un-audited financial results of the Company for the quarter / three months ended 30.06.2022 & the Un-audited financial results of the Company for the quarter / half year ended 30.09.2022 the Un-audited financial results of the Company for the quarter / three months ended 30.06.2022 & the Un-audited financial results of the Company for the quarter / half year ended 30.09.2022 (As Per BSE Announcement Dated on 14.11.2022)
25-Aug-2022	02-Sep-2022	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2022 inter alia to consider and approve Standalone Unaudited Financial Results For The Quarter Ended 30.06.2021 30.09.2021 31.12.2021 & Audited Financial Results For The Year Ended 31.03.2022 Considered and adopted the Un-audited financial results of the Company for the quarter ended 30.06.2021, 30.09.2021, 31.12.2021 & audited financial results of the Company for the quarter / year ended 31.03.2022 (As Per BSE Announcement dated on 02.09.2022) Appointment of Mr.Rakle Mathur Nath (DIN: 00589621), Dr.Prabhakar Korada (DIN:09717775) & Mr. Gangadharuni Durga Narasimha Kumar (DIN: 00661401) as Independent Directors of the Company for a term of five years effective from 30.09.2022 to 29.09.2027, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting, Mr.Amit Kumar Singh (DIN: 01824426) as Managing Director of the Company for a term of five years effective from 30.09.2022 to 29.09.2027, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting and Mr.Arvind Deviprasad Sharma as Chief Financial Officer (CFO) of the Company (As per BSE Announcement Dated on 3/9/2022)
25-Aug-2022	01-Sep-2022	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2022 inter alia to consider and approve Standalone unaudited financial results for the quarter ended 30.06.2020 30.09.2020 31.12.2020 & audited financial results for the year ended 31.03.2021 Outcome of the Board Meeting held on 01.09.2022 to consider and adopt Un-audited financial results of the Company for Q1, Q2 & Q3 and audited financial results of the Company for Q4. Un-audited financial results of the Company for the quarter / three months ended 30.06.2020 Un-audited financial results of the Company for the quarter / half year ended 30.09.2020 Un-audited financial results of the Company for the quarter / nine months ended 31.12.2020 Audited financial results of the Company for the quarter / year ended 31.03.2021 (As per BSE Announcement Dated on 1/9/2022)
24-Aug-2022	30-Aug-2022	Quarterly Results	Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2022 inter alia to consider and approve Prior Intimation of the Board Meeting to be held on 30.08.2022 to consider and take on record the Un-audited financial results of the Company for the quarter / half year ended 30.09.2019 Pursuant to Regulation 30 and 33 of SEBI (Listing obligations and disclosure requirements) 2015, this is to inform you that the Board of Directors in their just concluded Board meeting held today have Considered and adopted the Un-audited financial results of the Company for the quarter ended 30.09.2019 & 31.12.2019 and audited financial results for the quarter / year ended 31.03.2020 Un-audited financial results of the Company for the quarter / half year ended 30.09.2019 Un-audited financial results of the Company for the quarter / nine months ended 31.12.2019 Audited financial results of the Company for the quarter / year ended 31.03.2020 (As Per BSE Announcement Dated on 30/08/2022)